Yestar Healthcare Holdings Co (HKSE:02393) PEG Ratio: N/A (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Yestar Healthcare Holdings Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Yestar Healthcare Holdings Co's PE Ratio without NRI is 0.00. Yestar Healthcare Holdings Co's 5-Year EBITDA growth rate is 0.00%. Therefore, Yestar Healthcare Holdings Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Yestar Healthcare Holdings Co's PEG Ratio or its related term are showing as below:


During the past 13 years, Yestar Healthcare Holdings Co's highest PEG Ratio was 0.60. The lowest was 0.20. And the median was 0.42.


HKSE:02393's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.855
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.

Yestar Healthcare Holdings Co  (HKSE:02393) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.

Yestar Healthcare Holdings Co PEG Ratio Related Terms

Yestar Healthcare Holdings Co PEG Ratio Historical Data

* Premium members only.

The historical data trend for Yestar Healthcare Holdings Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yestar Healthcare Holdings Co PEG Ratio Chart

Yestar Healthcare Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Yestar Healthcare Holdings Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

HKSE:02393 vs ABT, SYK, MDT: PEG Ratio Comparison

For the Medical Devices subindustry, Yestar Healthcare Holdings Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yestar Healthcare Holdings Co PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Yestar Healthcare Holdings Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Yestar Healthcare Holdings Co's PEG Ratio falls into.


Yestar Healthcare Holdings Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Yestar Healthcare Holdings Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Yestar Healthcare Holdings Co Business Description

Address No. 1, Lane 388, Kang’an Road, Room 1210-1213, 12th Floor, Building T1, Pudong New District, Shanghai, CHN
Yestar Healthcare Holdings Co Ltd is engaged in the manufacture, distribution, and sale of medical imaging products, distribution of In Vitro Diagnostic (IVD) products, and manufacture and sale of dental films. The Group has two reportable operating segments: Imaging printing products segment, which includes the manufacture and sale of colour photographic paper, industrial NDT x-ray films and PWB films, and trading of imaging equipment; and Medical products and equipment segment, which generates maximum revenue and includes manufacture and sale of medical dry films, medical wet films and dental films, and sale of medical equipment and diagnostic reagents. The Group operates its business in Mainland China.